Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Net income
Cardinal Health, Inc.'s net income for fiscal 2026 was $1.7B, up 8.67% from $1.6B in fiscal 2025. Over the past ten years it has ranged from −$3.7B (fiscal 2020) to $1.7B (fiscal 2026) — the current reading is the highest in ten years. Net income has risen for 4 consecutive fiscal years. Cardinal Health, Inc. ranks 3rd of 11 Medical Distribution companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $1.7B | 8.67% |
| FY2025 | $1.6B | 83.94% |
| FY2024 | $853.0M | 157.70% |
| FY2023 | $331.0M | — |
| FY2022 | −$937.0M | — |
| FY2021 | $612.0M | — |
| FY2020 | −$3.7B | — |
| FY2019 | $1.4B | 427.03% |
| FY2018 | $259.0M | (79.98%) |
| FY2017 | $1.3B | (9.57%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $400.0M | 5.26% |
| Mar 2026 | $380.0M | (19.32%) |
| Dec 2025 | $471.0M | 3.74% |
| Sep 2025 | $454.0M | 86.83% |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| MCK McKesson Corporation compare | $5.3B |
| COR Cencora, Inc. compare | $2.6B |
| CAH Cardinal Health, Inc. | $1.7B |
| HSIC Henry Schein, Inc. compare | $426.0M |
| AHG Akso Health Group Sponsored ADR compare | $15.6M |
| HKPD Cellyan Biotechnology Co., Ltd compare | −$180.4K |
| COSM Cosmos Health Inc. compare | −$24.4M |
| FOCL FocalTherics compare | −$39.0M |
| ACH Accendra Health, Inc. compare | −$302.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on CAH
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement